Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

130.40 

-1.00 -0.8%

as of Aug 21 '19

52 Week Range:

82.05 132.06


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including CZ, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated services, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 7.92
7.89
8.67
11.19
12.60
14.78
14.93
15.96
growth rate -0.4% 9.9% 29.1% 12.6% 17.3% 1.0% 6.9%
Earnings BIT 183.30
130.10
228.90
241.30
250.90
growth rate -29.0% 75.9% 5.4% 4.0%
Avg.PE 40.50
40.96
31.56
32.50
growth rate 1.1% -23.0% 3.0%
ROA 7.31
5.95
5.09
5.61
5.45
6.94
7.61
5.68
8.42
8.42
10.77
growth rate -18.6% -14.5% 10.2% -2.9% 27.3% 9.7% -25.4% 48.2% 0.0% 27.9%
ROE 17.69
13.62
10.84
11.79
11.66
13.73
13.64
9.65
13.41
12.57
15.46
growth rate -23.0% -20.4% 8.8% -1.1% 17.8% -0.7% -29.3% 39.0% -6.3% 23.0%
ROIC 11.11
9.24
8.09
8.86
8.50
10.19
10.61
8.05
11.14
10.98
13.82
growth rate -16.8% -12.5% 9.5% -4.1% 19.9% 4.1% -24.1% 38.4% -1.4% 25.9%
Cur. Ratio 2.30
2.32
2.57
1.94
2.13
2.75
2.61
2.14
2.66
2.66
3.15
growth rate 0.9% 10.8% -24.5% 9.8% 29.1% -5.1% -18.0% 24.3% 0.0% 18.4%
Quick Ratio 1.38
1.30
1.39
0.98
1.33
1.79
1.72
1.45
1.67
1.75
2.21
growth rate -5.8% 6.9% -29.5% 35.7% 34.6% -3.9% -15.7% 15.2% 4.8% 26.3%
Leverage 2.40
2.19
2.07
2.14
2.15
1.84
1.75
1.66
1.54
1.46
1.42
growth rate -8.8% -5.5% 3.4% 0.5% -14.4% -4.9% -5.1% -7.2% -5.2% -2.7%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 179.00
181.40
200.50
253.20
288.20
growth rate 1.3% 10.5% 26.3% 13.8%
Acct.Payable 103.10
119.80
122.00
138.10
130.40
growth rate 16.2% 1.8% 13.2% -5.6%
Cur.Assets 659.10
673.70
641.90
743.50
894.40
growth rate 2.2% -4.7% 15.8% 20.3%
Total Assets 1,669.70
1,695.10
1,716.70
1,862.80
1,978.90
growth rate 1.5% 1.3% 8.5% 6.2%
Cash 255.30
274.60
203.00
235.90
337.40
growth rate 7.6% -26.1% 16.2% 43.0%
Inventory 181.50
181.10
199.30
215.20
214.50
growth rate -0.2% 10.1% 8.0% -0.3%
Cur.Liabilities 252.50
314.30
241.00
279.50
283.70
growth rate 24.5% -23.3% 16.0% 1.5%
Liabilities 712.80
671.20
599.20
582.90
582.60
growth rate -5.8% -10.7% -2.7% -0.1%
LT Debt 311.70
230.90
226.20
197.00
196.00
growth rate -25.9% -2.0% -12.9% -0.5%
Equity 956.90
1,023.90
1,117.50
1,279.90
1,396.30
growth rate 7.0% 9.1% 14.5% 9.1%
Common Shares 72.00
72.00
73.00
74.00
71.00
71.00
72.00
73.00
75.00
75.00
75.00
growth rate 0.0% 1.4% 1.4% -4.1% 0.0% 1.4% 1.4% 2.7% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 111.90
131.60
170.20
130.80
104.70
growth rate 17.6% 29.3% -23.2% -20.0%
Cash Dividends 29.10
32.40
35.80
39.10
42.10
growth rate 11.3% 10.5% 9.2% 7.7%
Cash From OA 182.90
212.40
219.40
263.30
288.60
growth rate 16.1% 3.3% 20.0% 9.6%
FCF per Share 0.52
0.27
0.77
0.89
0.95
0.61
1.16
2.23
growth rate -48.1% 185.2% 15.6% 6.7% -35.8% 90.2% 92.2%
Sale Purchase of Stock 17.10
15.90
29.70
43.90
growth rate -7.0% 86.8% 47.8%
FCF -4.00
29.00
65.00
33.00
55.00
65.00
70.00
80.00
49.00
133.00
184.00
growth rate 100.0% 124.1% -49.2% 66.7% 18.2% 7.7% 14.3% -38.8% 171.4% 38.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 1,421.40
1,399.80
1,509.10
1,599.10
1,717.40
growth rate -1.5% 7.8% 6.0% 7.4%
Op.Income 183.30
130.10
228.90
241.30
250.90
growth rate -29.0% 75.9% 5.4% 4.0%
IBT 174.30
121.90
198.00
231.60
248.30
growth rate -30.1% 62.4% 17.0% 7.2%
Net Income 127.10
95.60
143.60
150.70
206.90
growth rate -24.8% 50.2% 4.9% 37.3%
EPS 1.25
1.06
0.94
1.08
1.15
1.57
1.75
1.30
1.91
1.99
2.74
growth rate -15.2% -11.3% 14.9% 6.5% 36.5% 11.5% -25.7% 46.9% 4.2% 37.7%
Gross Profit 447.80
455.80
501.40
512.90
545.40
growth rate 1.8% 10.0% 2.3% 6.3%
R&D 37.30
34.10
36.80
39.10
40.30
growth rate -8.6% 7.9% 6.3% 3.1%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 62.80
65.10
62.70
68.30
77.70
growth rate 3.7% -3.7% 8.9% 13.8%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 296.70
302.90
288.20
318.20
330.80
growth rate 2.1% -4.9% 10.4% 4.0%
Acct.Payable 126.20
125.20
130.40
137.70
152.10
growth rate -0.8% 4.2% 5.6% 10.5%
Cur.Assets 766.90
850.10
894.40
867.60
944.30
growth rate 10.9% 5.2% -3.0% 8.8%
Total Assets 1,873.70
1,946.10
1,978.90
2,036.20
2,123.20
growth rate 3.9% 1.7% 2.9% 4.3%
Cash 225.50
297.30
337.40
265.50
326.70
growth rate 31.8% 13.5% -21.3% 23.1%
Inventory 208.20
206.80
214.50
226.10
232.30
growth rate -0.7% 3.7% 5.4% 2.7%
Cur.Liabilities 287.60
288.80
283.70
301.10
313.20
growth rate 0.4% -1.8% 6.1% 4.0%
Liabilities 591.80
594.30
582.60
666.70
678.10
growth rate 0.4% -2.0% 14.4% 1.7%
LT Debt 196.40
196.20
196.00
195.50
196.00
growth rate -0.1% -0.1% -0.3% 0.3%
Equity 1,281.90
1,351.80
1,396.30
1,369.50
1,445.10
growth rate 5.5% 3.3% -1.9% 5.5%
Common Shares 18.80
18.80
18.80
18.80
18.80
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 20.20
26.50
30.00
28.80
28.30
growth rate 31.2% 13.2% -4.0% -1.7%
Cash Dividends 10.30
10.30
11.10
11.10
11.10
growth rate 0.0% 7.8% 0.0% 0.0%
Cash From OA 82.00
88.40
73.20
47.60
105.10
growth rate 7.8% -17.2% -35.0% 120.8%
Sale Purchase of Stock 8.20
growth rate
FCF 61.80
61.90
43.20
18.80
76.80
growth rate 0.2% -30.2% -56.5% 308.5%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 447.50
431.70
422.50
443.50
469.70
growth rate -3.5% -2.1% 5.0% 5.9%
Op.Income 62.80
65.10
62.70
68.30
77.70
growth rate 3.7% -3.7% 8.9% 13.8%
IBT 62.10
63.20
66.90
71.50
81.60
growth rate 1.8% 5.9% 6.9% 14.1%
Net Income 56.10
55.20
52.00
55.40
66.10
growth rate -1.6% -5.8% 6.5% 19.3%
Gross Profit 142.20
135.60
133.20
146.80
157.90
growth rate -4.6% -1.8% 10.2% 7.6%
R&D 10.80
10.10
9.80
9.80
9.60
growth rate -6.5% -3.0% 0.0% -2.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (85.66)

YOY Growth Grade:

C (63.03)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 42.95 43.19
EPS / Growth 3.02

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.4%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 10.4% 10.4% 10.4%
Future PE 0.01 21.27 21.27
Future EPS 8.13 8.13 8.13
Value Price
MOS %
0.02
-100.0%
42.76
-67.2%
42.76
-67.2%
MOS Price 0.01 21.38 21.38
IRT 16.38 16.38 16.38

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.